Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy-Reference-Cited by-同舟云学术

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

Published:2018-05-10 Issue:5 Volume:13 Page:e0196395
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Offor Obiageli^ORCID,Utay Netanya,Reynoso David,Somasunderam Anoma,Currier Judith,Lake Jordan

Funder

Merck IISP Grant

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients;H Domingos;Brazilian Journal of Infectious Diseases,2009

2. Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy;CG Morse;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2015

3. A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome;MW Sonderup;Hepatology,2015

4. High Molecular Weight (HMW): total adiponectin ratio is low in hiv-infected women receiving protease inhibitors;F Omar;BMC clinical pathology,2014

5. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients;J Macias;Hepatology,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimens;AIDS;2022-06-21

2. Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment;Frontiers in Immunology;2021-06-18

3. The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes;Clinical Infectious Diseases;2020-03-13

4. HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells;PLOS ONE;2020-01-23

5. Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease;Infectious Diseases;2019-06-20